Efficacy of transurethral resection of prostate in patients of benign prostatic hyperplasia with lower urinary tract symptoms

Transurethral resection of the prostate (TURP) has been the prime procedure for decenniums to treat benign prostatic hyperplasia (BPH), but is mainly predicated on historic data that lacks utilization of validated measures. It is noteworthy that TURP done nowadays significantly differs from that performed 30 years ago. Men who had undergone TURP between 2013 and 2018 were reviewed. 50 patients presented in the Department of Urology, Lahore General Hospital, Pakistan, with lower urinary tract symptoms (LUTS) due to BPH (without retention) were recruited in the study. Related/required investigations were done and patients were operated for TURP after noting certain parameters. They were advised for follow up at 3 intervals (1st, 4th and 12th week postoperatively) and post-operative parameters were compared with pre-operative ones. International Prostate Symptom Score (IPSS), Quality of Life (QOL) and peak urinary flow rate (Qmax), and Post-Void Residual (PVR) were recorded. Operative details and postoperative complications were documented. Patients were then invited to attend for repeat assessment. Out of 50, 43(86%) patients had severe symptom score and 07 (14%) had moderate symptoms score (pre-operative). Out of total 50, 36 (72%) patients had Qmax less than 10 ml/s and 14 (28%) patients had Qmax between 10 and 15 ml/s as well as Post Micturition Residual Urine (PMRU) more than 50 ml pre-operatively. After 3 months of successful TURP, 49 (98%) patients’ conditions improved and they developed a normal flow rate of more than 20 to 25 ml/s. All the 50 patients remained with a PMRU of less than 50 ml. There was an improvement in 47 patients and only 3 patients did not improve to their satisfaction. TURP is very effective and still considered a gold standard treatment for BPH with LUTS without retention of urine. Key words: TURP, BPH, LUTS, PMRU